Cargando…
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer
BACKGROUND: Macrophage migration inhibitory factor (MIF) is a cytokine associated with prostate cancer, based on histologic evidence and circulating (serum) levels. Recent studies from another laboratory failed to document these results. This study's aims were to extend and confirm our previous...
Autores principales: | Meyer-Siegler, Katherine L, Iczkowski, Kenneth A, Vera, Pedro L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1177932/ https://www.ncbi.nlm.nih.gov/pubmed/16000172 http://dx.doi.org/10.1186/1471-2407-5-73 |
Ejemplares similares
-
Cyclophosphamide-Induced Cystitis Increases Bladder CXCR4 Expression and CXCR4-Macrophage Migration Inhibitory Factor Association
por: Vera, Pedro L., et al.
Publicado: (2008) -
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells
por: Meyer-Siegler, Katherine L, et al.
Publicado: (2004) -
Substance P Increases Cell-Surface Expression of CD74 (Receptor for Macrophage Migration Inhibitory Factor): In Vivo Biotinylation of Urothelial Cell-Surface Proteins
por: Meyer-Siegler, Katherine L., et al.
Publicado: (2009) -
Anatomical location of Macrophage Migration Inhibitory Factor in urogenital tissues, peripheral ganglia and lumbosacral spinal cord of the rat
por: Vera, Pedro L, et al.
Publicado: (2003) -
Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysis
por: Vera, Pedro L, et al.
Publicado: (2011)